Screening for Unrecognized HFpEF in Atrial Fibrillation and for Unrecognized Atrial Fibrillation in HFpEF
JACC: Heart Failure · 2024-06 · 12 (6) · 990-998
DOI: 10.1016/j.jchf.2024.04.010 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift JACC: Heart Failure, 2024-06. Verfasst von Yogesh N V Reddy und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: reddy.yogesh@mayo.edu. Hauptthemen laut MEDLINE: Atrial Fibrillation, Heart Failure, Stroke Volume. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: NHLBI.
Abstract (Originalsprache)
Because of the bidirectional relationship between atrial fibrillation (AF) and heart failure with preserved ejection fraction (HFpEF), individuals with either condition require consideration of screening for the other. In this review, we summarize current evidence and rationale for screening for occult HFpEF in adults with clinical AF; and occult AF in patients with clinically recognized HFpEF. Assessment of pretest probability for occult HFpEF in symptomatic AF patients may help guide additional testing such as exercise right heart catheterization to diagnose HFpEF and guide HFpEF-specific therapies. In patients with HFpEF, AF screening will identify cases of occult AF where anticoagulation may decrease stroke risk, and correlation of previously unknown AF episodes with paroxysmal symptoms may prompt consideration for rhythm control. Therefore, screening may help clinicians understand the etiology of the often-overlapping symptoms, and it may help guide treatments to slow progression of both conditions and their complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: reddy.yogesh@mayo.edu.
- Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA.
- Cleveland Clinic Health System, Cleveland, Ohio, USA.
Förderung
- NHLBI
Zitieren
APA
Reddy, Y. N. V., Noseworthy, P., Borlaug, B. A., & Albert, N. M. (2024). Screening for Unrecognized HFpEF in Atrial Fibrillation and for Unrecognized Atrial Fibrillation in HFpEF. JACC: Heart Failure, 12(6), 990-998. https://doi.org/10.1016/j.jchf.2024.04.010
Vancouver
Reddy YNV, Noseworthy P, Borlaug BA, Albert NM. Screening for Unrecognized HFpEF in Atrial Fibrillation and for Unrecognized Atrial Fibrillation in HFpEF. JACC: Heart Failure. 2024;12(6):990-998. doi:10.1016/j.jchf.2024.04.010
BibTeX
@article{Reddy2024,
author = {Reddy, Yogesh N V and Noseworthy, Peter and Borlaug, Barry A and Albert, Nancy M},
title = {Screening for Unrecognized HFpEF in Atrial Fibrillation and for Unrecognized Atrial Fibrillation in HFpEF},
journal = {JACC: Heart Failure},
year = {2024},
volume = {12},
number = {6},
pages = {990--998},
doi = {10.1016/j.jchf.2024.04.010}
}
EUVIMED